Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee S Schwartzberg

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
The Journal of Supportive Oncology|March 21, 2007
Chemotherapy-induced nausea and vomiting: clinician and patient perspectivesLee S Schwartzberg
Oncology (Williston Park, N.Y.)|August 25, 2007
Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?Lee S Schwartzberg
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2017
Use of Biomarkers and Multigene Assays in Breast CancerLee S Schwartzberg
Clinical Cornerstone|March 24, 2007
Neutropenia: etiology and pathogenesisLee S Schwartzberg
The Journal of Supportive Oncology|August 27, 2004
Managing the toxicity of hematopoietic stem cell transplantArnel M Pallera, Lee S Schwartzberg
Therapeutic Advances in Medical Oncology|December 5, 2019
Biosimilars for breast cancer: a review of HER2-targeted antibodies in the United StatesEmily M Miller, Lee S Schwartzberg
Advances in Therapy|May 26, 2018
Safety of Polysorbate 80 in the Oncology SettingLee S Schwartzberg, Rudolph M Navari
Journal of the Advanced Practitioner in Oncology|June 22, 2018
Collaborative Management of Patients With Estrogen Receptor-Positive Breast CancerLee S Schwartzberg, Heather R Greene
Journal of the Advanced Practitioner in Oncology|February 18, 2021
Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of TreatmentsHeather R Greene, Lee S Schwartzberg
Oncotargets and Therapy|October 17, 2018
Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomitingRudolph M Navari, Lee S Schwartzberg
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Supportive Oncology|March 21, 2007
Chemotherapy-induced nausea and vomiting: clinician and patient perspectivesLee S Schwartzberg
Oncology (Williston Park, N.Y.)|August 25, 2007
Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?Lee S Schwartzberg
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2017
Use of Biomarkers and Multigene Assays in Breast CancerLee S Schwartzberg
Clinical Cornerstone|March 24, 2007
Neutropenia: etiology and pathogenesisLee S Schwartzberg
The Journal of Supportive Oncology|August 27, 2004
Managing the toxicity of hematopoietic stem cell transplantArnel M Pallera, Lee S Schwartzberg
Therapeutic Advances in Medical Oncology|December 5, 2019
Biosimilars for breast cancer: a review of HER2-targeted antibodies in the United StatesEmily M Miller, Lee S Schwartzberg
Advances in Therapy|May 26, 2018
Safety of Polysorbate 80 in the Oncology SettingLee S Schwartzberg, Rudolph M Navari
Journal of the Advanced Practitioner in Oncology|June 22, 2018
Collaborative Management of Patients With Estrogen Receptor-Positive Breast CancerLee S Schwartzberg, Heather R Greene
Journal of the Advanced Practitioner in Oncology|February 18, 2021
Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of TreatmentsHeather R Greene, Lee S Schwartzberg
Oncotargets and Therapy|October 17, 2018
Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomitingRudolph M Navari, Lee S Schwartzberg
Pageof 14